Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.23.1
Consolidated Statements of Cash Flows
$ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Cash Flows From Operating Activities      
Net income $ 512.0 $ 459.1 $ 262.8
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 172.6 161.8 135.0
Lease expense 23.4 23.2 17.0
Deferred income taxes 48.4 49.8 85.8
Stock-based compensation 15.7 9.0 18.0
Asbestos adjustments loss 37.0 131.7 143.9
Excess tax benefits from share-based awards (0.2) (2.4) (3.5)
Gain on sale of land (12.7) 0.0 0.0
Loss on early debt extinguishment 0.0 0.0 13.1
Other, net 22.7 17.7 20.3
Changes in operating assets and liabilities:      
Accounts and other receivables 32.1 (70.9) 46.4
Inventories (70.8) (64.3) 98.7
Lease assets and liabilities, net (19.0) (19.2) (19.1)
Prepaid expenses and other assets (12.3) (5.7) (14.2)
Insurance receivable - Asbestos 6.2 8.3 5.8
Accounts payable and accrued liabilities (63.2) 136.7 25.0
Claims and handling costs paid - Asbestos (107.9) (118.8) (106.4)
Income taxes payable 5.5 0.2 (14.7)
Other accrued liabilities 18.1 41.0 73.0
Net cash provided by operating activities 607.6 757.2 786.9
Cash Flows From Investing Activities      
Purchases of property, plant and equipment (591.3) (257.8) (110.7)
Proceeds from sale of property, plant and equipment 14.1 0.0 1.6
Capitalized interest (8.5) (1.9) (9.5)
Purchase of restricted investments - Asbestos (180.1) (114.6) (25.0)
Proceeds from restricted investments - Asbestos 105.7 26.1 23.2
Net cash used in investing activities (660.1) (348.2) (120.4)
Cash Flows From Financing Activities      
Proceeds from credit facilities 450.0 390.0 0.0
Repayments of credit facilities (260.0) (350.0) (130.0)
Repayment of senior unsecured notes 0.0 0.0 (400.0)
Call redemption premium paid to note holders 0.0 0.0 (9.5)
Debt issuance costs 0.0 (2.1) 0.0
Proceeds from issuance of shares 0.2 0.3 0.1
Repayment of finance lease obligations and borrowings (1.5) (1.0) (0.8)
Shares repurchased (78.4) 0.0 0.0
Dividends paid (129.6) (484.0) 0.0
Taxes paid related to net share settlement of equity awards (6.1) (2.8) 0.0
Net cash used in financing activities (25.4) (449.6) (540.2)
Effects of exchange rate changes on cash and cash equivalents, restricted cash and restricted cash - Asbestos (8.4) (5.9) 6.3
Net (decrease) increase in cash and cash equivalents, restricted cash and restricted cash - Asbestos (86.3) (46.5) 132.6
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at beginning of period 271.9 318.4 185.8
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at end of period 185.6 271.9 318.4
Non-Cash Investing and Financing Activities      
Capital expenditures incurred but not yet paid 34.7 32.3 18.0
Supplemental Disclosure of Cash Flow Activities      
Cash paid during the year for interest 41.0 37.0 56.4
Cash payment (refund) during the year for income taxes, net 117.1 92.7 (3.7)
Cash paid to AICF $ 109.6 $ 248.5 $ 153.3